The North-West Inter Regional Female Cohort for Patients With Endometriosi
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Endometriosis
- Sponsor
- University Hospital, Rouen
- Enrollment
- 1500
- Locations
- 1
- Primary Endpoint
- Recurrences
- Last Updated
- 6 years ago
Overview
Brief Summary
All women managed for endometriosis are included and followed up through the CIRENDO database.
Information is obtained from surgical and histological records and from self-questionnaires completed before surgery. Standardized gastrointestinal questionnaires (KESS, GIQLI, WEXNER, FIQL and Bristol) are routinely used to assess bowel function. Data recording, patient contact and follow-up are carried out by a clinical research technician. Postoperative follow-up is based on data from the afore-mentioned questionnaires completed at 1, 3, 5 and 7 years.
Detailed Description
All women managed for endometriosis are included and followed up through the CIRENDO database (the North-West Inter Regional Female Cohort for Patients with Endometriosis), a prospective cohort financed by the G4 Group (The University Hospitals of Rouen, Lille, Amiens and Caen), and coordinated by the principal investigator (H.R.). Information is obtained from surgical and histological records and from self-questionnaires completed before surgery. Standardized gastrointestinal questionnaires (KESS, GIQLI, WEXNER, FIQL and Bristol) are routinely used to assess bowel function. Data recording, patient contact and follow-up are carried out by a clinical research technician. Women are included in the CIRENDO database only when endometriosis is confirmed by both surgical exploration and biopsy. Postoperative follow-up is based on data from the afore-mentioned questionnaires completed at 1, 3, 5 and 7 years. Prospective data recording and analysis were approved by the French authorities CNIL (Commission Nationale de l'Informatique et des Libertés) and CCTIRS (Comité Consultatif pour le Traitement de l'Information en matière de Recherche dans le domaine de la Santé).
Investigators
Eligibility Criteria
Inclusion Criteria
- •Endometriosis revealed on histological specimens
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Recurrences
Time Frame: 7 years
rate of recurrences at 1,3,5 and 7 years postoperatively
Secondary Outcomes
- Risk factors for endometriosis(1 year)
- Digestive functional outcomes(7 years)
- Fertility(7 years)